These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35451336)

  • 21. Outcomes of early and reversible renal impairment in patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Khoury S; Margolis G; Ravid D; Rozenbaum Z; Keren G; Shacham Y
    Eur Heart J Acute Cardiovasc Care; 2020 Oct; 9(7):684-689. PubMed ID: 30328697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of contrast-induced nephropathy with bare metal stent restenosis in STEMI patients treated with primary PCI.
    Güngör B; Karataş MB; İpek G; Özcan KS; Çanga Y; Onuk T; Keskin M; Hayıroğlu Mİ; Karadeniz FÖ; Sungur A; Öztürk R; Bolca O
    Ren Fail; 2016 Sep; 38(8):1167-73. PubMed ID: 27436614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex-Related Differences in Short- and Long-Term Outcome among Young and Middle-Aged Patients for ST-Segment Elevation Myocardial Infarction Underwent Percutaneous Coronary Intervention.
    Fu WX; Zhou TN; Wang XZ; Zhang L; Jing QM; Han YL
    Chin Med J (Engl); 2018 Jun; 131(12):1420-1429. PubMed ID: 29893358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration.
    Jolly SS; James S; Džavík V; Cairns JA; Mahmoud KD; Zijlstra F; Yusuf S; Olivecrona GK; Renlund H; Gao P; Lagerqvist B; Alazzoni A; Kedev S; Stankovic G; Meeks B; Frøbert O
    Circulation; 2017 Jan; 135(2):143-152. PubMed ID: 27941066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of combination therapy of statin and N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Park SH; Jeong MH; Park IH; Choi JS; Rhee JA; Kim IS; Kim MC; Cho JY; Sim DS; Hong YJ; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    Int J Cardiol; 2016 Jun; 212():100-6. PubMed ID: 27045874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):E40-E55. PubMed ID: 31423723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
    Liu Y; Hong D; Wang AY; Guo R; Smyth B; Liu J; Sun G; Chen S; Tan N; Jardine M; Brieger D; Shaman A; Islam S; Chen J; Gallagher M
    BMC Cardiovasc Disord; 2019 Apr; 19(1):87. PubMed ID: 30961544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between Acidosis Soon After Reperfusion and Contrast-Induced Nephropathy in Patients With a First-Time ST-Segment Elevation Myocardial Infarction.
    Gohbara M; Hayakawa A; Akazawa Y; Furihata S; Kondo A; Fukushima Y; Tomari S; Endo T; Kimura K; Tamura K
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28835362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Echocardiographic correlates of left ventricular filling pressures and acute cardio-renal syndrome in ST segment elevation myocardial infarction patients.
    Flint N; Kaufman N; Gal-Oz A; Margolis G; Topilsky Y; Keren G; Shacham Y
    Clin Res Cardiol; 2017 Feb; 106(2):120-126. PubMed ID: 27550512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between in-hospital mortality and creatinine/albumin in patients with ST-elevation myocardial infarction without standard modifiable risk factors.
    Yılmaz MF; Karagöz A; Zeren G; Avcı İI; Timur B; Sungur MA; Kalkan S; Şimşek B; Can F; Acar E; Tanboğa İH; Karabay CY
    Biomark Med; 2022 Oct; 16(14):1043-1053. PubMed ID: 36062571
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Centola M; Lucreziotti S; Salerno-Uriarte D; Sponzilli C; Ferrante G; Acquaviva R; Castini D; Spina M; Lombardi F; Cozzolino M; Carugo S
    Int J Cardiol; 2016 May; 210():4-9. PubMed ID: 26921538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Different Risk Scores for Predicting Contrast Induced Nephropathy and Outcomes After Primary Percutaneous Coronary Intervention in Patients With ST Elevation Myocardial Infarction.
    Liu YH; Liu Y; Zhou YL; He PC; Yu DQ; Li LW; Xie NJ; Guo W; Tan N; Chen JY
    Am J Cardiol; 2016 Jun; 117(12):1896-903. PubMed ID: 27161818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for in-hospital death in acute ST-segment elevation myocardial infarction after emergency percutaneous coronary intervention: a multicenter retrospective study.
    Gao N; Qi XY
    Ann Palliat Med; 2021 Nov; 10(11):11756-11766. PubMed ID: 34872300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Serum Cytochrome c on Contrast-Induced Nephropathy in Patients with ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Tang C; Hou J; Yan G; Qiao Y; Wang D; Zhu B; Liu B; Luo E; Nawabi AQ; Chen L
    Biomed Res Int; 2019; 2019():9357203. PubMed ID: 30809550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry.
    Bailleul C; Aissaoui N; Cayla G; Dillinger JG; Jouve B; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
    Arch Cardiovasc Dis; 2018 Feb; 111(2):101-108. PubMed ID: 28939193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Female gender and contrast-induced nephropathy in primary percutaneous intervention for ST-segment elevation myocardial infarction.
    Lucreziotti S; Centola M; Salerno-Uriarte D; Ponticelli G; Battezzati PM; Castini D; Sponzilli C; Lombardi F
    Int J Cardiol; 2014 Jun; 174(1):37-42. PubMed ID: 24698233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy.
    Falkentoft AC; Rørth R; Iversen K; Høfsten DE; Kelbæk H; Holmvang L; Frydland M; Schoos MM; Helqvist S; Axelsson A; Clemmensen P; Jørgensen E; Saunamäki K; Tilsted HH; Pedersen F; Torp-Pedersen C; Kofoed KF; Goetze JP; Engstrøm T; Køber L
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29776961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CHA2DS2-VASc score predicts contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction, who have undergone primary percutaneous coronary intervention.
    Cicek G; Yıldırım E
    Kardiol Pol; 2018; 76(1):91-98. PubMed ID: 28980300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of serum albumin-to-creatinine ratio in patients with acute myocardial infarction: Results from the retrospective evaluation of acute chest pain study.
    Liu H; Zhang J; Yu J; Li D; Jia Y; Cheng Y; Zhang Q; Liao X; Liu Y; Wu J; Zeng Z; Cao Y; Zeng R; Wan Z; Gao Y
    Medicine (Baltimore); 2020 Aug; 99(35):e22049. PubMed ID: 32871964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the preventive efficacy of rosuvastatin versus atorvastatin in post-contrast acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Dai Y; Huang J; Zeng L; Huang Z; Duan C; Shao S; Chen H; Xue L; Chen J; Tan N; He P; Liu Y; Yu D
    Biomed Pharmacother; 2020 Aug; 128():110336. PubMed ID: 32521452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.